Clinical Trial Update: Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing daptomycin plus meropenem versus ceftazidime for nosocomial spontaneous bacterial peritonitis in cirrhosis with ascites was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis
• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Daptomycin (daptomycin)
• Meropenem (Meropenem)
• ceftazidime (ceftazidime)

Snippet

Sponsor: University of Padova | Conditions: Cirrhosis, Ascites | Phase 2, Phase 3 | Status: TERMINATED